Quick Facts
FONT-SIZE Plus   Neg
Share SHARE
mail  E-MAIL

Illumina Urges Stockholders To Turn Down Roche's Offer & Vote For Its Nominees

4/9/2012 9:18 AM ET

Illumina, Inc. (ILMN: Quote) said it is sending a letter from its Board of Directors highlighting supportive reports issued by two of the nation's leading proxy advisor firms. The company's Board recommends that stockholders reject Roche's (RHHBY.PK) offer and vote for the election of its highly qualified nominees at its 2012 Annual Meeting of Stockholders by completing the WHITE proxy card on April 9, 2012.

Illumina also urged its shareholders to vote the WHITE PROXY CARD to re-elect to the Board four highly qualified and experienced directors, Blaine Bowman; Karin Eastham; Jay Flatley, President and CEO; and William Rastetter, Chairman.

Click here to receive FREE breaking news email alerts for Illumina Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Stocks moved sharply higher over the course of the trading day on Friday, more than offsetting the weakness seen on Thursday. In a reversal from the previous session, the markets benefited from some upbeat U.S. economic data as well as comments from a Federal Reserve official. The major averages saw further upside going into the close, with the Dow and the S&P 500 reaching new record highs. As the IRS targeting scandal continues to make headlines, animal-protection charity People for the Ethical Treatment of Animals, or PETA, claims that conservative groups are not the only ones that have faced increased scrutiny from the agency. While the IRS targeting scandal has taken center stage on Capitol Hill on Friday, the results of a new Gallup poll showed that the American public's interest in the story is comparatively low based on historical measures. The poll showed that 54 percent of Americans are following the news that the IRS targeted conservative groups for greater scrutiny "very" or "somewhat" closely.
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.